Taiwan’s National Science and Technology Council Minister Wu Cheng-wen has announced that an understanding has been established between Taiwan and the United States regarding the exemption of semiconductor products from American tariffs. During an interview with the Financial Times that was made public on November 20, Wu explained
China finds itself preparing another round of property market interventions as the nation’s real estate sector approaches its sixth consecutive year of decline. Alongside Japan’s planned $150 billion fiscal stimulus announcement, Chinese authorities are evaluating various policy options to revitalize their struggling housing market amid growing fears that
Moderna outlined its three-year strategic plan and pipeline developments during an Analyst Day presentation, projecting revenue growth reaching 10 percent in 2026 while making progress toward achieving cash flow breakeven by 2028. The biotechnology company, led by CEO Stéphane Bancel, indicated its strategy centers on developing a robust seasonal
The competitive pursuit of Avadel Pharmaceuticals has intensified, with Alkermes presenting a revised acquisition proposal worth up to $22.50 per share. This enhanced bid comes after Lundbeck submitted an unexpected proposal valued at as much as $23 per share, surpassing Alkermes’ initial offer of up to $20 per share.
Agios Pharmaceuticals experienced a significant stock decline following the release of Phase 3 clinical trial data for its anemia medication Pyrukynd on Wednesday, November 19, 2025. The experimental treatment showed partial success in treating sickle cell disease, achieving one primary endpoint while falling short on another critical measure. The drug,
Antibiotic resistance may be creating one of the biggest crises and opportunities, in modern medicine, and companies like BiomX (NYSE:PHGE) could be sitting at the center of the solution. Using precision-engineered viruses known as phages to hunt down antibiotic-resistant bacteria, BiomX is advancing next-generation therapies for
From Tel Aviv to San Francisco, the AI-coding boom is reshaping how software is built and exposing startups to global security risks
As concerns over America’s fragile power grid grow, a little-known microcap, Duke Robotics (OTCQB: DUKR), is emerging as an innovative player to watch. The company’s drone technology clean and maintain high-voltage electric insulators, reducing the risk of blackouts at a time when grid reliability has become
Your Salesforce CPQ contract renewal is approaching. For many revenue leaders, this moment triggers a familiar pattern: assess current performance, negotiate pricing, sign for another term, and move on. But 2025 presents a fundamentally different decision landscape. With Salesforce CPQ entering end-of-life status and the broader revenue operations
2025 marked a turning point for Inspira Technologies (NASDAQ: IINN). The company’s FDA-cleared INSPIRA ART100 system, which delivers extracorporeal life support through advanced blood oxygenation, made the leap from concept to clinical use. In April 2025, physicians at Westchester Medical Center in New York completed the first successful
As Washington prepares for what could become the most significant federal cannabis reform in half a century, InterCure (NASDAQ:INCR) is quietly positioning itself ahead of the curve. A leading GMP-certified medical cannabis producer, the company is reinforcing its scientific foundation just as U.S. policy momentum accelerates. When
In a groundbreaking announcement, PayPal has revealed a strategic partnership with OpenAI to integrate its payment services directly into ChatGPT, causing the payment processor’s stock to surge dramatically in premarket trading. The collaboration introduces a revolutionary “chat-to-checkout” feature that promises to transform how users make purchases through
